Quick and reliable solutions for 2019 coronavirus disease(COVID-19) and SARS-CoV-2.

• Accuracy: Assay 3 target genes unique to SARS-CoV-2 having higher specificity and exhibiting lower risk for mutation
• Specificity: Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2.
• Simplicity: Ready to use all-in-one master mix reagents and controls minimize variability
• Throughput: Two kit package options of viral detection for up to 94 specimens
• High quality, high performance and reliability

The GS™ COVID-19 RT-PCR KIT provides accurate, reproducible, high-quality results for clinical decision-making for patients with suspected COVID-19 (coronavirus) infection. The GS™ COVID-19 RT-PCR KIT performs a qualitative molecular assay that allows the detection of SARS-COV-2 nucleic acids in samples from patients who meet COVID-19 clinical and/or epidemiological criteria.

The GS™ COVID-19 RT-PCR KIT is a real-time reverse transcription polymerase chain reaction (RT-PCR) test which detects three genes from the SARS-CoV-2 virus from clinical nasopharyngeal swab specimens. In addition, the GS™ COVID-19 RT-PCR KIT also includes an internal positive control gene (GUSB) that serves as an extraction, reverse transcription, and PCR amplification control for each sample to minimize false negative results.

The GS™ COVID-19 RT-PCR KIT runs on the Applied Biosystems™ 7500 Fast Dx Real-Time PCR Instrument. Kits are available for the 96 well plate (22 clinical samples) and 384 well plate (94 clinical samples) and provides test results in less than 90 minutes.